Aflibercept shown to work at higher dose, longer intervals
3 Drugs for an Eye Disease, With Big Price Gaps, Are Found to Be Equals for Many - The New York Times
FDA Approves Additional Dosing Schedule for Eylea in Wet AMD - MPR
Eylea Full Prescribing Information, Dosage & Side Effects | MIMS Thailand
Retinal Physician - June 2022
Incidence of severe rise in intraocular pressure after intravitreous injection of aflibercept with prefilled syringes | Scientific Reports
High-Dose Eylea's Improved Durability Could Protect Regeneron's Market Share :: Scrip
Daily Medication Pearl: Aflibercept (Eylea)
BioCentury - Regeneron aims to extend Eylea franchise as high-dose aflibercept hits in Phase III
Eylea in Single-Dose Prefilled Syringe Now Available - MPR
High-Dose Aflibercept
Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration | Eye
Regeneron's Eylea approved for preterm infants with ROP
High-Dose Aflibercept
Regeneron's bid for high-dose Eylea scores early win, but the 'all important' data are still to come: analysts | Fierce Pharma
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration
g13251moi006.gif
Lucentis and Eylea patent expirations in the micro-crystal ball | Ophthalmology Innovation Source
EYLEA® Dosing for Diabetic Retinopathy | EYLEA® (aflibercept) Injection
Bayer, Regeneron's eye drug shown to work at higher dose, longer intervals | Reuters
High-Dose Aflibercept
Biotech's important data reveals | Evaluate
Aflibercept supports vision improvement in DME and wet AMD
Early Phase 2 data with high-dose aflibercept promising in wet AMD
Regeneron Presents Encouraging Phase 2 Results for High-dose Aflibercept 8 mg in Wet Age-related Macular Degeneration at Angioge
